Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iteos Therapeutics Inc (NQ: ITOS )

10.48 -0.20 (-1.87%)
Streaming Delayed Price Updated: 11:13 AM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50,666
Open 10.62
Bid (Size) 10.47 (2)
Ask (Size) 10.50 (1)
Prev. Close 10.68
Today's Range 10.45 - 10.62
52wk Range 8.200 - 18.24
Shares Outstanding 35,763,742
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
From iTeos Therapeutics Inc.
Via GlobeNewswire
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q4 2023
ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace

Performance

YTD
-9.58%
-9.58%
1 Month
+2.14%
+2.14%
3 Month
-7.26%
-7.26%
6 Month
+17.89%
+17.89%
1 Year
-24.82%
-24.82%

More News

Read More
Recap: ITeos Therapeutics Q4 Earnings
Via Benzinga
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Participate in Upcoming Investor Conferences
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
From iTeos Therapeutics Inc.
Via GlobeNewswire
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
From iTeos Therapeutics Inc.
Via GlobeNewswire
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
iTeos to Participate in Upcoming Investor Conferences
From iTeos Therapeutics Inc.
Via GlobeNewswire
Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update
Via Benzinga
S&P 500 Gains 1%; Analog Devices Posts Downbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Up Triple Digits, Headed for Much-Needed Win
Via Talk Markets
Topics Stocks
Exposures US Equities
Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why ITeos Therapeutics (ITOS) Stock Is Moving Higher
Via Benzinga
Crude Oil Edges Lower; VCI Global Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Nasdaq Rises 1%; US Manufacturing PMI Falls In August
Via Benzinga
Topics Stocks
Exposures US Equities
How Roche's Accidental Cancer Update Lifted Iteos And Arcus More Than 30%
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.